Patents by Inventor Wen-Wen Chou

Wen-Wen Chou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of Let-7g to down regulate NS5B gene, core protein and viral load of hepatitis C virus
    Patent number: 9738942
    Abstract: A method for evaluating the therapeutic efficacy of interferon (IFN)/ribavirin (RBV) for hepatitis C is disclosed. The method includes the steps of providing a specimen; mixing the specimen, a primer of a miRNA Let-7g and a poly-chain reaction (PCR) reagent together; and evaluating the efficacy of IFN/RBV on inhibiting a hepatitis C virus according to the expressing level of the miRNA Let-7g in the specimen detected by the PCR reagent.
    Type: Grant
    Filed: March 31, 2014
    Date of Patent: August 22, 2017
    Assignee: KAOHSIUNG MEDICAL UNIVERSITY
    Inventors: Chia-Yen Dai, Ming-Lung Yu, Wan-Long Chuang, Wen-Wen Chou
  • USE OF LET-7G TO DOWN REGULATE NS5B GENE, CORE PROTEIN AND VIRAL LOAD OF HEPATITIS C VIRUS
    Publication number: 20160251734
    Abstract: A method for evaluating the therapeutic efficacy of interferon(IFN)/ribavirin(RBV) for hepatitis C is disclosed. The method includes the steps of providing a specimen; mixing the specimen, a primer of a miRNA Let-7g and a poly-chain reaction(PCR) reagent together; and evaluating the efficacy of IFN/RBV on inhibiting a hepatitis C virus according to the expressing level of the miRNA Let-7g in the specimen detected by the PCR reagent.
    Type: Application
    Filed: March 31, 2014
    Publication date: September 1, 2016
    Applicant: KAOHSIUNG MEDICAL UNIVERSITY
    Inventors: Edward HSI, Ming-Lung YU, Wan-Long CHUANG, Chia-Yen DAI, Wen-Wen CHOU
  • METHOD OF MODULATING COMPLEMENT FACTOR B (CFB) EXPRESSION IN CELLS
    Publication number: 20120245108
    Abstract: The present invention relates to a method of modulating complement factor B (CFB) expression in cells, comprising administering an effective amount of tannic acid to the cells. This method can be applied in treating or prophylaxis of the disease, disorder or medical condition associated to complement factor B (CFB) expression.
    Type: Application
    Filed: March 23, 2011
    Publication date: September 27, 2012
    Applicant: KAOHSIUNG MEDICAL UNIVERSITY
    Inventors: Suh-Hang Hank Juo, Wen-Wen Chou, Jing-Mei Wu, Chung-Ling Liang